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Objective: To investigate promoters and barriers for cervical cancer screening in rural Tanzania. Methods: We
interviewed 300 women of reproductive age living in Kiwangwa village, Tanzania. The odds of attending a
free, 2-day screening service were compared with sociodemographic variables, lifestyle factors, and knowledge
and attitudes surrounding cervical cancer usingmultivariable logistic regression.Results: Comparedwithwomen
who did not attend the screening service (n = 195), women who attended (n = 105) were older (OR 4.29;
95% CI, 1.61–11.48, age 40–49 years versus 20–29 years), listened regularly to the radio (OR 24.76; 95% CI,
11.49–53.33, listened to radio 1–3 times per week versus not at all), had a poorer quality of life (OR 4.91; CI,
1.96–12.32, lowest versus highest score), had faced cost barriers to obtaining health care in the preceding year
(OR 2.24; 95% CI, 1.11–4.53, yes versus no), and held a more positive attitude toward cervical cancer screening
(OR 4.64; 95% CI, 1.39–15.55, least versus most averse). Conclusion: Efforts aimed at improving screening rates
in rural Tanzania need to address both structural and individual-level barriers, including knowledge and aware-
ness of cervical cancer prevention, cost barriers to care, and access to health information.
© 2013 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
Cervical cancer disproportionately afflicts women living in poverty
[1]. Although the disease is largely preventable, over half a million
women worldwide develop invasive cervical cancer each year, the ma-
jority of whom reside in low- and middle-income countries [2]. Of the
275 000 women who die annually from cervical cancer, 80% live in
low-income countries [3]. Tanzania, one of the poorest countries in
the world, has an incidence rate that is 1.6 times the average rate in
East Africa, the region with the highest cervical cancer incidence rate
on the continent [4].
The method of visual inspection with acetic acid (VIA) has been
championed as a viable, low-cost alternative to the Pap smear for the
early detection of cervical cancer in resource-poor settings [5]. Since
2002, the Ocean Road Cancer Institute in Dar es Salaam, currently the
only specialized cancer hospital in Tanzania, has helped to expand
VIA services throughout the country [6,7]. Screening services remain
limited, however, with only 12 of the 21 regions having access to atrive, Ann Arbor, MI 48105, USA.
ration of Gynecology and Obstetrics. Pleast 1 health center providing VIA [8]. Moreover, it is estimated that
as little as 5% of the target population in Tanzania, women 30–50 years
of age, have ever been screened, and reports from referral hospitals re-
veal that the vast majority of cervical cancer patients are still presenting
at late stages of the disease [6,9–11].
Screening uptake and disease outcomes are generally worse in rural
areas compared with urban areas because the rural population is sub-
stantially poorer and access to health services is logistically more diffi-
cult [1,12]. Although expansion efforts have brought cervical cancer
screening (CCS) to new regions, with 74 active screening sites as of
March 2012, nearly all active sites are situated in urban communities,
which comprise less than a quarter of Tanzania’s population [8,13].
Considering that over 75% of the women of reproductive age live in
rural communities without ready access to CCS, the true burden of
cervical cancer incidence and mortality is likely to be greater among
underserved rural women than the national estimates suggest.
Limited access to CCS in rural communities combinedwith lowcoun-
trywide screening rates has prompted ourmultidisciplinary group to in-
vestigate impactable promoters and barriers to CCS in rural areas. Our
overarching hypotheses are that low use of CCS is attributable to both
structural factors, such as cost barriers and access to health information,
and individual-level factors, such as disease awareness and health prac-
tices. Factors affecting uptake of CCS among underserved women in aublished by Elsevier Ireland Ltd. All rights reserved.
Fig. 1. Diagram of recruitment strategy. Between March and May 2012, 202 womenwere
interviewed at home; in June 2012, 98 women were interviewed at the 2-day screening
service. Seven women who had been interviewed at home also attended the screening
service, and their data were pooled with those for the 98 women interviewed at the ser-
vice. In total, 227 women attended the service from the village. Abbreviations: F, female;
M, male.
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future CCS programs tailored to rural settings.
2. Materials and methods
The present study was conducted in Kiwangwa, Tanzania, a rural
village located 110 km northwest of Dar es Salaam in the Bagamoyo
District. Bagamoyo is comprised of 102 villages and is one of 6 districts
in the coastal region of Tanzania [13]. We chose Kiwangwa because it
was accessible to us fromDar es Salaam, and its age and sex distribution
as well as infrastructure and sociodemographics were comparable with
that in other rural villages in the district [13]. Its 9145 residents (4766
women, 4379men) and2351 households are distributed over 9 hamlets
[14]. Approximately 30% of women in Kiwangwa are 30 years of age or
older—the recommended age atwhich seronegativewomen in Tanzania
should begin triennial screening for cervical cancer [13,15]. The vastma-
jority of the villagers are farmers, speak only Kiswahili, and do not have
electricity or running water. The average daily wage for a laborer in
Kiwangwa is 2950 Tanzanian shillings, the equivalent of US $1.85 [14].
The village has a health dispensary that provides basic outpatient
care for sick children and adults, maternal and child health services,
and testing and treatment for major infectious diseases. The dispensary
employs 1 physician, 2 nurses, 3 health orderlies, and 2 community
health workers. The dispensary does not offer CCS.
A 25-minute, interviewer-administered questionnaire was designed
referencing concepts from previously validated survey instruments and
focusing on individual and structural factors that could influence
screening use [10,16,17]. We developed the survey in English with our
Tanzanian team members, and it was translated into Kiswahili with
the assistance of a professional language instructor. Approval to conduct
the present study was obtained from the Institutional Review Boards at
the University of Michigan, Ann Arbor, MI, USA, and the National Insti-
tute for Medical Research in Dar es Salaam. Two trained community
health workers were hired from the Kiwangwa health dispensary to as-
sist with administering the interviews in Kiswahili. Following 50 pre-
test interviews, minor wording changes were made to improve ques-
tion comprehension. We met with the community health workers on
a weekly basis to supervise data collection and monitor survey quality.
Basic sociodemographic information was collected, including age,
years of residence, marital status, parity, and education level. General
health practices, which included habit of treating drinking water, use of
cigarettes and oral contraceptives, and access to health services, were
also examined. Index variableswere created to assess constructs—quality
of life (QOL), decision-making autonomy, and knowledge and attitudinal
constructs—that the team decided would be best measured using multi-
ple questions (Supplementary Material S1).
We interviewed 300 women from March 14 to June 8, 2012. Of
these, 202 women were recruited at home from March 14 to May 8,
2012; 98 women were recruited during an organized screening inter-
vention from June 7 to 8, 2012 (Fig. 1).
To ensure proportional representation from each hamlet during
home interviews, convenience quota sampling was used to recruit par-
ticipants in proportion to the number of households in each hamlet.
We then randomly recruited 1 woman who was 25 years or older
from each household. Each participant was read a text explaining the
study aims and provided written consent. A minimum of 15 minutes
was set aside after each interview to educate the participant and her
family about cervical cancer. Only 6 women declined to be interviewed
because of household work.
In June 2012, we sponsored a 2-day CCS service at the Kiwangwa
health dispensary. A week prior to the service, flyers advertising the
service were posted at the local school and marketplace. Motorcycle
messengers were hired to disseminate the message via megaphone
through each hamlet on 3 separate days prior to the service. During
the service, women were recruited for interviews at random from
the waiting area. The survey, consent forms, and interview protocolswere the same as those used in the home interviews, the only additional
requirement being that women could not have been previously
interviewed during home visits. All women who were approached
agreed to participate.
The final analytic sample comprised 300 women, 105 of whom
attended the screening service (Fig. 1). Of the women who attended
the screening, 7 had participated in the home interviews, and the
remaining 98 were interviewed on-site at the CCS service. In the analy-
sis, data for the 7 home-interviewedwomenwere pooledwith those for
the 98 women who went directly to the service.
To identify predictors of screening, the odds of screening attendance
were examined with respect to sociodemographic and lifestyle vari-
ables. Odds ratios and 95% confidence intervals (CIs) were compared
across categories of these variables using logistic regression. The signif-
icance of these associations was assessed using theWald test for a main
effect. For ordinal variables, a test of linear trend was obtained.
Next, we assessed the relation between the odds of attendance
and women’s knowledge and perceptions surrounding cervical cancer;
attitudes toward screening; attitudes toward the health system; basic
disease knowledge; decision-making autonomy; and QOL. Each domain
was measured using multiple questions with responses recorded either
as “Yes/No” or as a score on a3- or 5-level Likert scale. Three-level indices
were then created based on these scores (Supplementary Material S1).
To assess the statistical significance of the associations, we tested for a
linear trend across levels of each index.
Finally, to construct the multivariable model, a stepwise selection
procedure was used to determine the final set of indices to retain in
the model. The fully loaded model included all indices and socio-
demographic and lifestyle variables that were significant in the uni-
variate analysis at P b 0.05. In these models, we deliberately avoided
adjustment for covariates that could be on the causal pathway between
the indices and attending screening. Excluding the 7women interviewed
at home produced no difference in the direction,magnitude, or statistical
significance of the results. All analyses were carried out with SAS version
9.2 (SAS Institute, Cary, NC, USA).
3. Results
In total, 227 women from the village attended the screening service
and 16 (7.0%) screened positive for pre-cancerous lesions. These
women were contacted the following month and were provided
with free cryotherapy surgery treatment. Of the women who attended
Table 1
Odds ratio of attending cervical cancer screening according to sociodemographic
characteristics and general health practices among women from Kiwangwa, Tanzania.
Parameter Total
number
(n = 300)
Attended
screening
(n = 105)a
OR (95% CI) P valueb
Age 0.005
20–29 y 101 26 (25.7) Reference
30–39 y 104 42 (40.4) 1.95 (1.08–3.54)
40–49 y 56 26 (46.4) 2.50 (1.26–4.98)
≥50 y 32 5 (15.6) 0.53 (0.19–1.53)
Missing 7 6 (85.7) —
Currently married or
cohabiting
0.24
Yes 216 80 (37.0) 1.39 (0.81–2.39)
No 84 25 (29.8) Reference
Years at current residence 0.04
0 to b2 64 15 (23.4) Reference
2 to b4 80 29 (36.3) 1.86 (0.89–3.88)
4 to b9 77 25 (32.5) 1.57 (0.74–3.32)
≥9 77 36 (46.8) 2.87 (1.38–5.96)
Missing 2 0 (0.0) —
Education level b0.001
No formal education 62 4 (6.5) Reference
Some primary
education
23 5 (21.7) 4.03 (0.98–16.62)
Complete primary
or higher
193 74 (38.3) 9.02 (3.14–25.87)
Missing 22 22 (100.0) —
Parity 0.35
0–2 98 33 (33.7) Reference
3–4 96 38 (39.6) 1.29 (0.72–2.32)
5–6 58 15 (25.9) 0.69 (0.33–1.41)
≥7 47 18 (38.3) 1.22 (0.59–2.52)
Missing 1 1 (100.0) —
Treats drinking water 0.06
No 209 66 (31.6) Reference
Yes 91 39 (42.9) 1.63 (0.98–2.70)
Oral contraceptive use 0.15
No 162 51 (31.5) Reference
Yes 137 54 (39.4) 1.42 (0.88–2.28)
Missing 1 0 (0.0) —
Ever smoked 0.56
No 291 102 (35.1) 1.62 (0.32–8.16)
Yes 8 2 (25.0) Reference
Missing 1 1 (100.0) —
Attends regular physical
check-up
b0.001
Yes 226 94 (41.6) 4.08 (2.04–8.15)
No 74 11 (14.9) Reference
Faced recent cost barriers
to health carea
0.03
No 171 51 (29.8) Reference
Yes 128 54 (42.2) 1.72 (1.06–2.78)
Missing 1 0 (0.0) —
Access to health clinic 0.37
1 (good) 144 54 (37.5) Reference
2 101 30 (29.7) 0.70 (0.41–1.21)
3 (poor) 54 21 (38.9) 1.06 (0.56–2.02)
Missing 1 0 (0.0) —
Radio use frequency b0.001
Not at all 195 28 (14.4) Reference
b1 time/week 19 11 (57.9) 8.20 (3.03–22.17)
1–3 times/week 73 57 (78.1) 21.24 (10.72–42.10)
≥4 times/week 13 9 (69.2) 13.42 (3.87–46.55)
Owns a radio 0.14
Yes 229 85 (37.1) 1.45 (0.82–2.65)
No 71 20 (28.6) Reference
Owns a telephone 0.21
Yes 202 75 (37.0) 1.34 (0.80–2.24)
No 98 30 (30.6) Reference
Access to transportation 0.23
Yes 201 75 (37.3) 1.37 (0.82–2.29)
No 99 30 (30.3) Reference
Abbreviations: CI, confidence interval; OR, odds ratio.
a Values are given as number (percentage).
b From theWald test ofmain effect. P values represent a test of trend for years at current
residence, education level, parity, access to health clinic, and radio use frequency.
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representing 3.5% of the home-interview group; 98/227 (43.2%) women
were interviewed during the screening service (Fig. 1).
In the univariate analysis (Table 1), the odds of attending screening
were related to age, with women in the 40–49-year age group having a
2.5 (95% CI, 1.26–4.98) times higher odds of attending screening than
those 20–29 years of age. The odds of screeningwere also positively re-
lated to the number of years at the current residence, the education
level, attendance of regular health check-ups, and radio use frequency.
Women who had experienced financial barriers to obtaining health
care in the preceding year had a 72% higher odds of attending screening
than those who had not experienced health-care-related financial is-
sues (P = 0.03).
The QOL score was negatively associated with screening atten-
dance (Table 2). In comparison with those with the highest QOL score,
womenwith the lowest score had a 2.73 times greater odds of attending
screening (P = 0.006). Cervical cancer awareness, risk factor knowl-
edge, attitude toward screening, and knowledge about screening were
each positively related to the odds of screening (Table 2).
In the multivariable analysis (Table 3), the positive relations of age,
recent financial issues with health care, radio use frequency, and atti-
tude toward CCS remained apparent. Additionally, women with the
lowest QOL score were nearly 5 times more likely to attend screening
than those in the highest score (P trend = 0.001).
4. Discussion
To explore factors that influence CCS in rural settings, a random sam-
ple of women living in rural households was compared with women
from the same village who attended a 2-day, inexpensively advertised
CCS intervention. The results indicate that in addition to knowledge
and attitudes regarding cervical cancer, broader social and structural
factors substantially influence a woman’s decision to obtain screening.
Age was positively associated with the odds of screening participa-
tion, with women 40–49 years of age demonstrating the highest odds
of attendance. Thisfinding is consistentwith previous studies conducted
in India and Sub-Saharan Africa [18,19]. The relation could be attribut-
able to older women having had more contact with reproductive health
services as a result of longer fertility histories [20].
Women who reported having experienced financial barriers to
obtaining medical care within the preceding year were more likely to
attend the service than their counterparts. In a health system where
patients often need to purchase their own supplies, it is possible that
the women who routinely accessed health services were more likely
to face cost barriers than those who did not visit the health clinics at
all. This rationale would concur with the positive association between
attending regular health check-ups and screening attendance. It is
also possible thatwomenwho had previously experienced cost barriers
to care were more likely to appreciate a service where all costs were
defrayed by the present study team, indicating that when cost barriers
to screening are removed, thewomenwho are less able to afford health
care are more likely to participate.
In a similar vein,womenwho reported a poorer QOLweremore like-
ly to attend the service. This challenged the prediction that domestic
priorities could be particularly salient barriers to screening for rural
women, who typically spendmore time performing reproductive, com-
munity, and householdwork than urbanwomen [21–23]. The perceived
absence of ill health, however, has also been reported as a deterrent
to screening [21]. Hence, it is possible that in the present population,
the womenwith a poorer QOLwere more receptive to the health inter-
vention than women who felt they were already healthy.
As hypothesized, women who held more positive attitudes toward
screening and had greater knowledge of cervical cancer were substan-
tially more likely to attend the service. Awareness of other diseases,
however, such as HIV, tuberculosis, and malaria, was unrelated to
screening attendance, which indicates that being health-literate in
Table 3
Adjusted odds ratios of attending cervical cancer screening according to social and
structural factors among women from Kiwangwa, Tanzania (n = 300).
Parameter Adjusted OR (95% CI)
of screening attendance
P valuec
Agea 0.02
20–29 y Reference
30–39 y 1.88 (0.83–4.25)
40–49 y 4.29 (1.61–11.48)
≥50 y 1.15 (0.31–4.23)
Faced recent cost barriers to health carea 0.03
No Reference
Yes 2.24 (1.11–4.53)
Radio use frequencyb b0.001
Not at all Reference
Once/week 11.45 (3.80–34.64)
1–3 times/week 24.76 (11.49–53.33)
≥4 times/week 17.40 (4.57–66.24)
Quality of lifea 0.001
1 (Poorest) 4.91 (1.96–12.32)
2 3.78 (1.48–9.62)
3 (Best) Reference
Cervical cancer screening attitudea 0.001
1 (most averse) Reference
2 1.62 (0.48–5.49)
3 (least averse) 4.64 (1.39–15.55)
Abbreviations: CI, confidence interval; OR, odds ratio.
a From a stepwise model selection procedure with a logistic regression model where
screening attendance was the outcome and predictors included age, experience of
healthcare financial issues in the preceding year, radio use frequency, basic needs, and
cervical cancer screening attitude.
b From a stepwise model selection procedure with a logistic regression model where
screening attendance was the outcome and predictors included age, experience of
healthcare financial issues in the preceding year, and radio use frequency.
c Represents a test for linear trend in which an indicator for an ordinal category of the
index was entered into a logistic regression model as a continuous variable for all
variables except “age” and “recent financial issues with health care” (Wald test).
Table 2
Odds ratio of attending cervical cancer screening according to perceptions, knowledge,
and attitudes surrounding cervical cancer and cervical cancer screening among women
from Kiwangwa, Tanzania.a
Parameter Total
number
(n = 300)
Attended
screening
(n = 105)b
OR (95% CI) P valuec
Quality of life 0.006
1 (poorest) 126 49 (38.9) 2.73 (1.44–5.17)
2 84 39 (46.4) 3.72 (1.89–7.35)
3 (best) 90 17 (18.9) Reference
Basic disease awareness 0.69
1 (lowest) 6 2 (33.3) Reference
2 26 8 (30.8) 0.89 (0.13–5.89)
3 (highest) 268 95 (35.5) 1.10 (0.20–6.11)
Cervical cancer awareness b0.001
1 (lowest) 57 8 (14.0) Reference
2 72 13 (18.1) 1.35 (0.52–3.52)
3 (highest) 160 74 (46.3) 5.27 (2.35–11.84)
Missing 11 10 (90.9) —
Cervical cancer risk factor
knowledge
b0.001
1 (poorest) 92 13 (14.1) Reference
2 105 36 (34.3) 3.17 (1.56–6.46)
3 (best) 103 56 (54.4) 7.24 (3.58–14.62)
Cervical cancer screening
attitude
b0.001
1 (most averse) 34 7 (20.6) Reference
2 123 30 (24.4) 1.24 (0.49–3.15)
3 (least averse) 142 68 (47.9) 3.54 (1.45–8.67)
Missing 1 0 (0.0) —
Cervical cancer screening
knowledge
b0.001
1 (poorest) 116 26 (22.4) Reference
2 130 51 (39.2) 2.24 (1.28–3.92)
3 (best) 54 28 (51.9) 3.73 (1.87–7.43)
Perceived threat of cervical
cancer
0.18
1 (lowest) 31 11 (35.5) Reference
2 59 13 (22.0) 0.51 (0.20–1.34)
3 (highest) 210 81 (38.6) 1.14 (0.52–2.51)
Decision-making autonomy 0.96
1 (lowest) 150 53 (35.3) Reference
2 82 28 (34.2) 0.95 (0.54–1.67)
3 (highest) 68 24 (35.3) 1.00 (0.55–1.82)
a See Supplementary Material S1 for index components.
b Values are given as number (percentage).
c Represents a test for linear trend in which the ordinal indicator was entered into a
logistic regression model as a continuous variable.
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realm of cervical cancer. Thus, targeted disease education and outreach
efforts aimed at cancer-prevention literacy are still critical to improving
screening use.
Lastly, and of particular relevance to building health literacy in rural
communities, a strong association was observed between listening
to the radio on a regular basis and screening attendance. The radio,
which has been reported as a prime source of cervical cancer informa-
tion for underserved populations, was highly adopted in the present
setting, with over 75% of surveyed households owning a radio [24].
These data indicate that public-health radio announcements on
cancer screening, such as those broadcasted by the Medical Women
Association of Tanzania, can be an effective means for mobilizing rural
women to seek screening.
The present study has several strengths. First, the study was
conducted in a representative rural setting where women were
recruited directly from the community; this approach helps eliminate
sampling bias that can arise from recruiting subjects exclusively at
health centers. Secondly, we examined knowledge and attitudes as
well as structural factors so as to inform a broader understanding of
screening barriers in rural settings. Third, the study design enabled the
assessment of differences between women who actively attended thescreening service and those who abstained. Lastly, beyond following a
research agenda, our team was also instrumental in procuring disease
education, screening, and treatment for a high-risk population at need
for these services.
The present study also had some limitations. First, although
Kiwangwa is considered to be representative of other villages in the dis-
trict, sampling froma single site limits the generalizability of thepresent
findings to other rural settings. Second, the use of convenience quota
sampling within the village encouraged subject recruitment from the
most accessible homes. Third, a 2-day screening intervention might
not have fully captured all women who had wished to attend.
In summary, individual-level factors, including age, QOL, knowledge
and awareness about disease, aswell as structural factors, such as access
to media and cost barriers to health care, were identified as modifiable
predictors of CCS use among women of reproductive age in rural
Tanzania. Continued research in the area of rural health outcomes is
needed not only to better understand the situation faced by rural
women but also to inform the rationale of cancer prevention and treat-
ment services for women with the lowest resources and access.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijgo.2013.05.026.
Acknowledgments
Thepresent studywas supported by a Fulbright Programgrant spon-
sored by the Bureau of Educational and Cultural Affairs of the United
States Department of State and administered by the Institute of Interna-
tional Education. The study was also supported by the Cancer Epidemi-
ology Education in Special Populations program of the University of
Nebraska (Omaha, NE, USA; grant R25 CA11 2383), the Avon Founda-
tion (A.S.S., S.D.M), and the Breast Cancer Research Foundation (S.D.M).
225P. Perng et al. / International Journal of Gynecology and Obstetrics 123 (2013) 221–225Conflict of interest
The authors have no conflicts of interest.References
[1] Palacio-Mejía LS, Rangel-Gómez G, Hernández-Avila M, Lazcano-Ponce E. Cervical
cancer, a disease of poverty: mortality differences between urban and rural areas
in Mexico. Salud Publica Mex 2003;45(Suppl. 3):S315–25.
[2] Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer:
priorities for prevention. Carcinogenesis 2010;31(1):100–10.
[3] Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of world-
wide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127(12):
2893–917.
[4] WHO/ICO Information Centre on HPV and Cervical Cancer. Human Papillomavirus
and Related Cancers in Tanzania. Summary Report. Published 2010.
[5] Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for
cervical cancer in low- and middle-income developing countries. Bull World Health
Organ 2001;79(10):954–62.
[6] Mwaiselage J. Outreach of Cervical Cancer Prevention Program in Tanzania: Achieve-
ments and Challenges. Published 2010.
[7] Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of
screening methods for cervical neoplasia. Int J Gynecol Obstet 2005;89(Suppl. 2):
S4–S12.
[8] Andrews L. Standard Operating Procedures for Implementation of Cervical Cancer
Screening and Early Treatment Program. Published 2012.
[9] Mosha D,MahandeM, Ahaz J, MoshaM, Njau B, Kitali B, et al. Factors associated with
management of cervical cancer patients at KCMC Hospital, Tanzania: a retrospective
cross-sectional study. Tanzan J Health Res 2009;11(2):70–4.
[10] Peters LM, Soliman AS, Bukori P, Mkuchu J, Ngoma T. Evidence for the need of
educational programs for cervical screening in rural Tanzania. J Cancer Educ
2010;25(2):153–9.[11] Kazaura MR, Kombe D, Yuma S, Mtiro H, Mlawa G. Health seeking behavior among
cancer patients attending Ocean Road Cancer Institute, Tanzania. East Afr J Public
Health 2007;4(1):19–22.
[12] Watkins MM, Gabali C, Winkleby M, Gaona E, Lebaron S. Barriers to cervical cancer
screening in rural Mexico. Int J Gynecol Cancer 2002;12(5):475–9.
[13] Central Census Office. 2002 Population and Housing Census: Village and street sta-
tistics age and sex distribution. Dar es Salaam: National Bureau of Statistics; 2003.
[14] Rashidi K. Takwimu za Kijiji (Village Data) Kiwangwa. Published 2012.
[15] TheUnited Republic of TanzanianMinistry of Health andSocialWelfare. Tanzania Ser-
vice Delivery Guidelines for Cervical Cancer Prevention and Control. Published 2011.
[16] Abotchie PN, Shokar NK. Cervical cancer screening among college students in ghana:
knowledge and health beliefs. Int J Gynecol Cancer 2009;19(3):412–6.
[17] Nguyen TT, McPhee SJ, Nguyen T, Lam T, Mock J. Predictors of cervical Pap smear
screening awareness, intention, and receipt among Vietnamese-American women.
Am J Prev Med 2002;23(3):207–14.
[18] Roy B, Tang TS. Cervical cancer screening in Kolkata, India: beliefs and predictors
of cervical cancer screening among women attending a women's health clinic in
Kolkata, India. J Cancer Educ 2008;23(4):253–9.
[19] Gichangi P, Estambale B, Bwayo J, Rogo K, Ojwang S, Opiyo A, et al. Knowledge and
practice about cervical cancer and Pap smear testing among patients at Kenyatta
National Hospital, Nairobi, Kenya. Int J Gynecol Cancer 2003;13(6):827–33.
[20] Lazcano-Ponce EC, Moss S, Cruz-Valdez A, de Ruíz PA, Martínez-León CJ, Casares-
Queralt S, et al. The positive experience of screening quality among users of a cervi-
cal cancer detection center. Arch Med Res 2002;33(2):186–92.
[21] Fort VK, Makin MS, Siegler AJ, Ault K, Rochat R. Barriers to cervical cancer screening
in Mulanje, Malawi: a qualitative study. Patient Prefer Adherence 2011;5:125–31.
[22] Logan L, McIlfatrick S. Exploring women's knowledge, experiences and perceptions
of cervical cancer screening in an area of social deprivation. Eur J Cancer Care
(Engl) 2011;20(6):720–7.
[23] Inter-Agency Task Force on Rural Women, United Nations. Rural Women and the
Millenium Development Goals. Published 2012.
[24] Tebeu PM, Major AL, Rapiti E, Petignat P, Bouchardy C, Sando Z, et al. The attitude
and knowledge of cervical cancer by Cameroonian women; a clinical survey
conducted in Maroua, the capital of Far North Province of Cameroon. Int J Gynecol
Cancer 2008;18(4):761–5.
